My research background
Nine countries in the region are endemic: Bangladesh, India, Indonesia, the Maldives, Myanmar, Nepal, Sri Lanka, h ailand and Timor-Leste. Filariasis elimination programmes and national plans of action are operational in all endemic countries. h e region’s i rst strategic plan for eliminating LF was developed in 2000; it has since been updated for the period 2010–2015. h e regional programme review group meets regularly to review national and regional progress made towards elimination, and considers countries’ applications for donations of medicine.
Of the 472 districts in Indonesia, 337 are endemic, with an at-risk population of more than 124 million. By 2009, the programme had expanded to include 99 endemic districts. Special population groups, called Tenaga Pelaksana Eliminasi, were used to distribute the medicine, either door-to-door or at booths in areas where the community usually congregates. However, MDA was discontinued fully or partially in seven provinces before the criteria for interrupted transmission were met owing to a lack of funds. Health services in a few districts of ered hydrocele surgery and support in managing lymphoedema; training programmes have been conducted at the provincial level.
Progress report 2000-2009 and strategic plan 2010-2020 of the global programme to eliminate lymphatic ﬁ lariasis: halfway towards eliminating lymphatic ﬁ lariasis.
Global Programme to Eliminate Lymphatic Filariasis
World Health Organization 2010